Principal Financial Group
CRBP icon

Principal Financial Group’s Corbus Pharmaceuticals CRBP Stock Holding History

Principal Financial Group’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-827
Closed -$25K – 2554
2021
Q3 		$25K Sell
827
-134
-14% -$5.29K ﹤0.01% 2562
2021
Q2 		$53K Sell
961
-118
-11% -$6.55K ﹤0.01% 2568
2021
Q1 		$64K Sell
1,079
-26
-2% -$1.71K ﹤0.01% 2446
2020
Q4 		$41K Buy
1,105
+264
+31% +$9.87K ﹤0.01% 2400
2020
Q3 		$45K Sell
841
-33
-4% -$5.98K ﹤0.01% 2296
2020
Q2 		$220K Buy
+874
New +$177K ﹤0.01% 2166

Other funds holding CRBP

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Principal Financial Group's CRBP Position: Q4 2021 in Review

Principal Financial Group sold out of Corbus Pharmaceuticals (CRBP) in Q4 2021, closing a stake of 827 shares — an estimated $25K sold.

Principal Financial Group first reported a position in CRBP in Q2 2020 and held it in 6 quarters. The position peaked at $220K in Q2 2020. 82 funds tracked by Wall St. Rank hold CRBP as of Q4 2021.

  • Principal Financial Group reported no remaining Corbus Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Principal Financial Group sold 827 Corbus Pharmaceuticals shares in Q4 2021, an estimated $25K.
  • Principal Financial Group first reported a position in Corbus Pharmaceuticals in Q2 2020 and held it in 6 quarters.
  • Principal Financial Group's Corbus Pharmaceuticals position peaked at $220K in Q2 2020.
  • 82 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2021.

Based on Principal Financial Group's 13F filing for Q4 2021, filed 9 Feb 2022.